BRÖSTCANCER - Karolinska Sjukhuset

Rutqvist LE, Pettersson D, Johansson H. Adjuvant radiation therapy versus surgery alone in operable breast
cancer: long-term follow-up of a randomized clinical trial. Radiother Oncol 1993; 26: 104-10.
Stal O, Dufmats M, Hatschek T, Carstensen J, Klintenberg C, Rutqvist LE, et al. S-phase fraction is a prognostic
factor in stage I breast carcinoma. J Clin Oncol 1993; 11: 1717-22.
1994
Cuzick J, Stewart H, Rutqvist LE, Houghton J, Edwards R, Redmond C, et al. Cause-specific mortality in longterm
survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994; 12: 447-53.
Gyenes G, Fornander T, Carlens P, Rutqvist LE. Morbidity of ischemic heart disease in early breast cancer 15-20
years after adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 1994; 28: 1235-41.
Gyenes G, Fornander T, Carlens P, Velander M, Rutqvist LE. Prinzmetal's angina following postoperative
adjuvant radiotherapy for right-sided breast cancer. Acta Oncol 1994; 33: 706-8.
Rutqvist LE. Randomized adjuvant breast cancer trials in Sweden. Cancer 1994; 74: 1156-9.
Stal O, Carstensen JM, Wingren S, Rutqvist LE, Skoog L, Klintenberg C, et al. Relationship of DNA ploidy and
S-phase fraction to survival after first recurrence of breast cancer. Acta Oncol 1994; 33: 423-9.
Stal O, Skoog L, Rutqvist LE, Carstensen JM, Wingren S, Sullivan S, et al. S-phase fraction and survival benefit
from adjuvant chemotherapy or radiotherapy of breast cancer. Br J Cancer 1994; 70: 1258-62.
von Schoultz E, Wilking N, Rutqvist LE, Theve T, von Schoultz B. [Estrogen therapy. Is breast cancer a
contraindication to hormonal substitution therapy?]. Lakartidningen 1994; 91: 1302-6.
1995
Arriagada R, Rutqvist LE, Mattsson A, Kramar A, Rotstein S. Adequate locoregional treatment for early breast
cancer may prevent secondary dissemination. J Clin Oncol 1995; 13: 2869-78.
Lidbrink E, Levi L, Pettersson I, Rosendahl I, Rutqvist LE, de la Torre B, et al. Single-view screening
mammography: psychological, endocrine and immunological effects of recalling for a complete threeview
examination. Eur J Cancer 1995; 31A: 932-3.
Mattsson A, Ruden BI, Palmgren J, Rutqvist LE. Dose- and time-response for breast cancer risk after radiation
therapy for benign breast disease. Br J Cancer 1995; 72: 1054-61.
Rutqvist LE, Johansson H, Signomklao T, Johansson U, Fornander T, Wilking N. Adjuvant tamoxifen therapy
for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. J
Natl Cancer Inst 1995; 87: 645-51..
Stal O, Stenmark Askmalm M, Wingren S, Rutqvist LE, Skoog L, Ferraud L, et al. p53 expression and the result
of adjuvant therapy of breast cancer. Acta Oncol 1995; 34: 767-70.
Stal O, Sullivan S, Wingren S, Skoog L, Rutqvist LE, Carstensen JM, et al. c-erbB-2 expression and benefit from
adjuvant chemotherapy and radiotherapy of breast cancer. Eur J Cancer 1995; 31A: 2185-90.
von Schoultz E, Johansson H, Wilking N, Rutqvist LE. Influence of prior and subsequent pregnancy on breast
cancer prognosis. J Clin Oncol 1995; 13: 430-4.
1996
Gagliardi G, Lax I, Ottolenghi A, Rutqvist LE. Long-term cardiac mortality after radiotherapy of breast cancer--
application of the relative seriality model. Br J Radiol 1996; 69: 839-46.
Gyenes G, Fornander T, Carlens P, Glas U, Rutqvist LE. Myocardial damage in breast cancer patients treated
with adjuvant radiotherapy: a prospective study. Int J Radiat Oncol Biol Phys 1996; 36: 899-905.
Gyenes G, Fornander T, Rutqvist LE. Radiation-induced cardiac disease. Am Heart J 1996; 131: 1236-8.
Rutqvist LE. Breast cancer. Acta Oncol 1996; 35 Suppl 7: 54-63.
Rutqvist LE. Radiation therapy in the primary management of early-stage breast cancer. Recent Results Cancer
Res 1996; 140: 241-50.
Rutqvist LE. Re: second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst 1996; Oct
16:88 (20): 1497-9; author reply 1497-9.
33